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In-vitro spectrometric analysis of
hyperlactatemia and lactic acidosis
in buffer relating to sepsis
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Abstract
The normal range for pH in the human body is 7.35-7.45. When pH falls below 7.3, it is considered as severe acidemia. 
Acidemia, together with increased blood lactate concentrations (hyperlactatemia) constitute a severe threat to life, which is 
often referred to as lactic acidosis. The feasibility of near infrared transmission/reflectance spectroscopy as a tool to 
determine lactate concentration levels and pH, independently, has been well established. However, the effects on spectral 
features arising from simultaneous variations in pH and lactate are not fully understood. Hence, this paper reports on a 
spectroscopic study of 37 different lactate concentrations that were prepared at three different pH levels (7.4, 7.0 and 6.5). 
Near infrared spectra were acquired in the range 800-2500 nm, and were later divided into four spectral ranges. Further 
investigations were carried out on various wavelengths within each spectral range and sample set. Furthermore, partial 
least squares regression with cross-validation was performed on all data sets. The results showed a clear interdependence 
and overlapping spectral behavior between blood lactate concentrations and pH. The findings from this study suggest that 
for an accurate estimation of blood lactate using this technique, the pH of the sample must be previously known.
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Introduction
Lactate is produced in the human body by an enzyme
known as lactate dehydrogenase (LDH), which reduces
pyruvate during anaerobic glycolysis. The formation
and disposal of lactate in the body are naturally bal-
anced, such that lactate concentrations in blood are
maintained at around  2mmolL–1.1 The human
body produces lactate at an approximate rate of
0.8mmol kg–1 body weight hour–1, and of this,
around 0.6mmol L–1 is typically found in arterial
blood and 0.9mmol L–1 in venous blood. However,
under conditions of hypoperfusion and hypoxia, the
entry of pyruvate into the Krebs cycle of aerobic res-
piration is reduced, which in turn, leads to increased
levels of lactate in blood.2
Elevated blood lactate levels, termed hyperlactate-
mia, is considered an important biomarker of mor-
bidity and mortality in critically-ill patients.3–7 For
this reason, routine measurement of blood lactate
concentration is important in various patient
groups,8 including patients with severe injury,9 post-
operative patients,10 and those with severe sepsis.11,12
The Surviving Sepsis Campaign (SSC), in their ’SSC
bundle: 2018 update’,13 have mentioned that sepsis is
a medical emergency and if the initial admission lac-
tate level is 2mmol L–1, resuscitation and manage-
ment should be started immediately. Lactate
concentrations should be re-measured within two
hours and again until they are stabilized. Blood lac-
tate concentration can be regarded as an indirect mea-
sure of tissue hypoperfusion. However, studies have
also shown that hyperlactatemia, together with the
degree of acidosis, is a better mortality predictor in
critical care patients with sepsis.14–16 The metabolic
acidosis (pH  7.35) which may be associated with
sepsis (pathogenesis) and hyperlactatemia is due to
the influence of lactate production and ionization
leading to a strong ionic compositional difference.17
Another important aspect to consider is that the time
between the inception of inadequate tissue perfusion
and death is very short, potentially less than 1 hour.18
The most recent study on this subject was carried out
in 2017,19 and reported a worldwide incidence of
sepsis at around 48.9 million people between 1990
to 2017, and the number of global sepsis-related
deaths at 11 million people (197% of global
deaths). This data has seen a recent spike in numbers
following the global pandemic of coronavirus disease
2019 (COVID-19). According to a study from
Wuhan, China, published in March 2020,20 sepsis
was the ubiquitous symptom in all 191 patients con-
sidered in the study.
A prompt and adequate hemodynamic resuscita-
tion protocol that incorporates continuous lactate
monitoring is thus, necessary. In present clinical
care settings, lactate is commonly measured by an
add on capability to arterial blood gas (ABG) analy-
sers that requires sampling of arterial blood, or via
venipuncture (sampling of venous blood). Also, meas-
urements performed using photometric or ampero-
metric techniques, which are the most commonly
used methods in critical care, may be subjected to
chemical interference and oxygen limitation.
Transmittance/reflectance spectroscopy has been
previously investigated as a means of identifying
clear and unique absorption peaks for lactate across
the NIR spectrum, both in-vitro and in-vivo. Many of
such studies were conducted by Lafrance et al.,21–23
where the optical regions of 1540–1740nm and 2050–
2400nm were utilised for lactate measurements in
human plasma and whole blood. These studies were
performed on a group of exercising individuals using
reflectance spectrometers, while blood sampling was
undertaken simultaneously. The motivation for this
study was to establish the feasibility and prediction
capability of non-invasive determination of lactate
concentration in varying localized muscle lactate. The
results of these studies provides the necessary confi-
dence that NIR transmission/reflectance spectroscopy
could be used to estimate lactate concentrations in-
vitro and in-vivo, though further investigation is
required to understand the effects of additional param-
eters in the spectra. As this study only considers lactate
levels within a healthy range, further investigations are
also necessary into the interaction of lactate with the
NIR spectrum at levels seen in critical care patients.
Previous studies have also reported spectrometric
investigations of lactate changes and varying pH sep-
arately,24–26 as well as the feasibility of NIR as a
potential tool for detection of these parameters.
Nevertheless, the effects of simultaneous variations
in these parameters are not yet fully understood,
and hence for the first time, this study provides an
analysis of the combined effects of hyperlactatemia
and lactic acidosis in an in-vitro set-up using NIR
spectroscopy in buffer solutions.
Reagents and materials
In order to see the effects of lactic acidosis on spectro-
scopic measurement in an in-vitro set up, three pH
buffer solutions (6.5, 7.0 and 7.4) were prepared. A
lactate stock solution of 600mmol L–1 was prepared
separately in de-ionized water and isotonic phosphate
buffer solution (PBS). Both Na-L-Lactate and salts for
the PBS were in dry form (analytical grade), and
obtained from Thermo Fisher Scientific (Waltham,
MA, USA). Isotonic PBS was used as a buffer to main-
tain a steady initial pH of 7.4 0.02 at 24 C, replicat-
ing physiological values. The pH of the buffer was
changed by adding drops of HCl into the solution.
Thereby, thirty seven samples of varying lactate con-
centrations for each set of pH buffer were prepared by
mixing aliquots of buffer and lactate stock solution.
The pH and temperature of all the solutions were mea-
sured by an Orion Star A211 Advanced pH Benchtop
Meter Kit, from Thermo Fisher Scientific, (Waltham,
MA, USA), immediately prior to measurement.
The concentrations of the thirty seven samples of
varying lactate concentration for each set of pH were:
0–5mmol L–1 with an iteration of 0.25mmol L–1 in
between each sample and then from 5-20mmol L–1
with an iteration of 1.0mmol L–1. The first set of
concentrations (0–5mmol L–1) emulates lactate con-
centration levels in critical care. However, the latter
set (5–20mmol L–1) reflects the localized lactate level
concentrations in muscle during strenuous physical
activity. An LM5 Lactate Analyzer from Analox
Instrument Limited, (Stourbridge, UK) was used to
test the concentration of each sample before
collecting the spectra. The reported range from the
manufacturer for a linear dependency for lactate is
0–10mmol L–1.
NIR spectroscopy
A Lambda 1050 dual beam spectrometer from Perkin
Elmer (Waltham, MA, USA), was used to collect three
spectra from each sample in the region 800-2600 nm
(NIR) with step increments of 1 nm. Thus, a total of
333 spectra were collected. These spectra were then
averaged and a total of 111 spectra were used in sub-
sequent analysis. The samples were chosen at random
from each set to prevent bias. The light source used
was a halogen-tungsten lamp. The detector settings are
as shown in Table 1. These were selected to prevent
oversaturation of all detectors due to high –OH absor-
bance in this region. In addition, the reference beam
Table 1. Detector settings for NIR spectroscopy.
Detectors
Wavelength
range (nm) Slit Size Gain
Response
time (s)
InGaAs 800–1800 Servo Mode 5 0.2
PbS 1800–2600 Servo Mode 1 0.2
was set at 1% attenuation for the purpose of noise
reduction at high absorbance values.
Baseline correction of 100% Transmittance/0%
Absorption was also added in the spectrophotometer
to reduce “background noise” or peaks arising from
the ambient environment. The samples were placed in
the sample holder of the spectrophotometer quartz
cuvettes (Hellma GmbH & Co. KG, Müllheim,
Germany) of 1mm path length.
Spectral analysis
The spectral viewing and analysis tasks were executed
on MATLAB R2020b, MathWorksTM (Natwick,
MA, USA).
Pre-processing of all the three sets of spectra was
performed separately to understand the effects of pH
on concentration changes of lactate. The first step was
to perform a spectral difference of the blank
(0mmol L–1 concentration of lactate) from all other
spectra. This step was followed by application of
Multiplicative Scatter Correction (MSC) on the
resulting spectra in the three sets independently to
minimize any multiplicative effects and to enhance
any spectral features. To further intensify and empha-
size the spectral absorption features and to reduce
noise, a Savitzky-Golay derivation (SG) was per-
formed on the three sets, separately. The values of
the polynomial order, derivative and window length
of the SG filter were maintained at 2, 1 and 71 respec-
tively. These values were decided as a trade-off
between noise suppression and feature enhancement
in the plots. The window size was decided after trial
and testing of different values (7, 31, 51 and 71).
A 2D correlation analysis was then performed on
the pre-processed spectra which provided an under-
standing of the systematic variations in spectral inten-
sities (both absorbance and wavelength) for different
pH sets. These variations could be seen as a result of
the induced changes in the spectra caused by the
changes in the concentration of lactate at each pH.
A partial least square (PLS) regression analysis with
leave-one-out cross-validation was carried out inde-
pendently for each data-set.
The predictions for each cycle was performed by
extracting orthogonal factors (also known as latent
variables (LVs)) from the training set for the best fit
of the model. The optimal number of LVs were deter-
mined by Predicted Residual Sum of Squares
(PRESS) for each set. Since this is a clear example
of a random effect model, the smallest values of
PRESS were used for each set. The accuracy of the
predictive models were measured using regression
analysis for the predicted concentration of lactate vs
actual (or known) concentration of lactate. The
parameters, coefficient of determination, (R2),
derived from the sum of squares, together with the
root mean squared error of cross validation
(RMSECV) for each set were used as indicators for
the regression models.
This process was also repeated and the data-sets
were chosen iteratively in a random manner, where,
two sets were used as calibration sets, in order to
predict the remaining set for testing the predictive
performance as the hold-out set.
Results and discussion
The three sets of raw and pre-processed absorption
spectra appeared similar to typical aqueous NIR
spectra and could be seen in Figure 1, where the
first data-set of pH 7.4 is depicted.
Since all samples contained a high degree of water,
absorption bands/peaks related to O-H bonds were
clearly evident in all acquired sets of measurement.
Three substantial water overtone bands could be
seen at around 1450 nm (asþbas, aþ b¼ 2),
1950 nm (asþ dsþ bas, aþb¼ 1), and 2500 nm
Figure 1. Raw spectra (left) and pre-processed NIR spectra of 37 lactate concentrations in PBS at pH 7.4.
(as where, a & b are integers 0),27,28 where, s is
symmetrical stretching, as is asymmetrical stretching
and ds is the symmetrical in-plane bending. Also,
minor –OH Absorbance peaks could be seen at wave-
lengths 1490 nm, 1540 nm, 1820 nm, 2070 nm and
2100 nm.29
As shown in the previous study,30 all bands of -OH
absorption experience linear hyperchromic shifts
(p-values  0.05) when pH is varied and the concen-
tration of lactate is kept constant. However, as seen in
Table 2, with the exception of wavelengths at
1820 nm, 1490 nm and 1540 nm, p-values were not
significant across all three sets. Hence, these wave-
lengths/bands could potentially act as windows for
NIR data-sets with changes in pH (lactic acidosis)
only without changes in lactate.
For the purpose of identifying wavelengths of
interest which relate to variations in lactate concen-
tration, 2D synchronous contour plots were con-
structed for all three sets. Minute highlights could
be seen in the regions between 1100–1350 nm, 1700–
1760 nm and 2200–2400 nm. These highlighted
changes were in between –OH absorption bands/
peaks for water. Linear Regression was performed
on the absorption values corresponding to the wave-
lengths for interest, in order to understand the statis-
tical significance of the lactate concentration changes
at each pH data-set.31
In the first spectral range, 1100–1350 nm, two
wavelengths, 1142 nm and 1233 nm were investigated.
At both the wavelengths, 1142 nm and 1233 nm,
linear correlations were observed for pH data-sets
7.4, 7.0 and 6.5.
The second spectral range 1700–1760 nm could be
identified in the spectra as a result of C–H stretch ()
1st overtone. Again, linear regression was performed
on two wavelengths, 1710 nm and 1750 nm. Except
for pH 7.4, they showed no significance in any of
the other sets.
Finally, in the last spectral region, 2200–2400 nm,
three wavelengths 2205 nm, 2319 nm and 2341 nm
were taken into consideration. The p-values of these
wavelengths suggested that they were linear for pH
data-sets 7.4 and 7.0.
Yano et al.32 performed similar experiments with
lactate concentration changes (100-300 g L1) in peri-
toneal dialysis solutions (usually with an acidic pH of
5.2–5.5). They assigned the wavelengths, 1268 nm and
1688 nm to the lactate molecule. These wavelengths,
as expected, did not correlate linearly in any of the
data-sets, as the pH of the medium was acidic com-
pared to those which were considered here. Lafrance
et al.21–23 performed a series of experiments in differ-
ent media, and considered different wavelength
ranges in each study. The studies were mainly focused
on higher concentrations of lactate and pH, varying
from 7.44–7.66 in whole blood and in 7.2 buffered
solution which was then mixed in serum to increase
the number of samples. Hence, the attributed wave-
lengths were not expected to be linear across all four
data-sets. While wavelengths 1675 nm, 1690 nm,
2166 nm and 2254 nm were linearly correlated
(p 0.05) for data-sets of pH 7.0 and 6.5, the wave-
lengths 1730 nm and 2292 nm were linear for the data-
set of pH 7.4, as well. Finally, in 2017, Kossowski
et al.,33 attributed wavelengths 823 nm, 923 nm and
1047 nm in the NIR region to lactic acid from their
in-vivo experiment with six LEDs (light source) and a
silicon pin diode (detector). The wavelengths 823 nm
and 923 nm were linear for the pH data-sets 7.4 and
7.0, while, the wavelength 1047 nm was linear for the
pH data-sets 7.0 and 6.5, respectively.
Hence, it may be assumed by the results displayed in
Table 3, that wavelengths pertinent to lactate are large-
ly dependent on the pH of the solution sample.
Previous studies have shown that the wavelengths,
1233nm, 1710nm, 1750nm, 2205nm, 2319nm and
2341nm vary in absorbance with respect to changes
in pH. These changes could be attributed to
Table 2. p-values of the linear regression done on the -OH Absorption wavelengths (nm) on data sets of pH 7.4, pH 6.5 and pH 7.0 with
varying concentrations of lactate. Significant p-values ( 0:05) are highlighted.
NIR Wavelength (nm)
Data Sets 970 1450 1490 1540 1820 2070 2100
pH 7.4 0.67 0.15 0.040 0.36 0.034 0.92 0.96
pH 7.0 0.88 0.0514 0.155 0.038 0.035 0.09 0.11
pH 6.5 0.66 0.79 1.86E-03 0.25 4.48E-03 0.42 0.66
Table 3. p-values of the linear regression done on wavelengths (nm) for data sets of pH 7.4, pH 6.5 and pH 7.0 with varying concen-
trations of lactate. Significant p-values  0:05 are highlighted.
NIR Wavelength (nm)
Data Sets 1142 1233 1710 1750 2205 2319 2341
pH 7.4 1.45E-05 1.39E-05 0.027 1.19E-05 5.41E-07 0.0016 0.032
pH 7.0 5.63E-08 0.008 0.69 0.34 6.52E-05 0.0081 0.0020
pH 6.5 0.0030 4.66E-04 0.854 0.23 0.044 0.56 0.22
ionization/de-protonation of lactic acid to lactate
(CH3CH(OH)COO
).30,34 Similarly, the changes in lac-
tate concentration within each pH set would also
ionize/de-protonate minute amounts of lactic acid to
lactate ion. However, these changes are infinitesimal
and thus, unlikely to appear in the acquired spectra.
This justifies the use of multivariate analysis based on
linear regression, using the whole spectral range, to fur-
ther understand the relevant spectral changes in all
three sets of measurements. For this purpose, Partial
Least Square regression analysis was performed on
individual data-sets to understand the effects of lactate
concentration variation or hyperlactatemia.
Figure 2 shows the Prediction Error Sum of Squares
results for three sets of acquired data. These results
were used to determine the number of Latent
Variables (LVs) to build prediction models for dimen-
tionality reduction.35 Therefore, predictive models were
built for all three data-sets using LVs 6, 5 and 8 for the
three pH data-sets 7.4, 7.0 and 6.5, respectively.
Figure 3, plots actual concentration of lactate vs
predicted concentrations by the three predictive PLS
models that were built using leave-one-out cross-vali-
dation analysis. The coefficients of determination R2
for each of the three sets are displayed in the figure.
As seen from Figure 3, R2, for the three data-sets
relating to pH 7.4, 7.0 and 6.5 were 0.94, 0.83 and
0.95, respectively. The root mean square error of
cross validation for the linear regression models of
observed vs the predicted concentrations of lactate
for the same data-sets were 0.58mmol L–1,
0.46mmol L–1 and 0.44mmol L–1, respectively. The
high RMSECV values could be an indication that
lactate concentration at higher values can be pre-
dicted accurately. However, due to a lower number
of samples in the three sets for the higher concentra-
tions of lactate, cross-validation was not performed.
These results are in-line with Lafrance et al.23
Moreover, to investigate the generalizability of
predictions into sets with different pH values, a
leave-one-pH (data-set)-out test set validation was
carried out, where pairs of pH sets were used for
training and the remaining set for testing. This led
to very poor predictive performance on all cases.
For example, when pH data-sets 7.4 and 6.5 were
used to build the models and predict the test set 6.5,
the R2 values were negative and the root mean
squared error of prediction (RMSEP) value was
56.32mmol L1. This means that the changes in
pH values influence the optical absorbance in a
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Figure 3. Predicted vs Actual plots for lactate concentration of 37 PBS samples.
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Figure 2. Prediction Error Sum of Squares (PRESS) versus number of latent variables (LV). (left) The number of LVs in the NIR spectral
region for pH 7.4 used was 6; (center) The number of LVs in the NIR spectral region for pH 7.0 used was 5; (right) The number of LVs in the
NIR spectral region for pH 6.5 used was 8.
non-linear manner, hence, such interrelationship
cannot be modelled using PLS and leave-one-pH
(dataset)-out test set validation. This is what was
expected from our previous analytical investigation,
where a change in pH from 6-8, while keeping the
lactate concentration constant at 2mmol L1
showed non-linear characteristics in the NIR spectral
region,30 unlike the MIR spectral region.31
Conclusion
In conclusion, the results of this work indicate that
there exists an influence of pH on the absorption spec-
trum of lactate, which could be seen in the spectral
features. In order to identify spectral changes occur-
ring as a result of lactate concentration changes (or
hyperlactatemia), which could be a potential reflec-
tion of the ionization of lactic acid to lactate in dif-
ferent regions of the NIR spectra were investigated.
This led to the assumption that the absorption bands
of water exhibit non-linear correlations with changes
in lactate concentration, and this is true for all
acquired pH data-sets. In turn, this indicates that
these peaks could be a marker for pH (or lactic aci-
dosis) determination alone. Nevertheless, specific
wavelengths within the NIR spectral region exhibit
a linear correlation in relation to the pH data-sets.
Variations in lactate concentration could be predicted
with more than 90% accuracy for each pH data-set
independently, but when combining multiple pH data
sets into the model, predictions results were non-
linear. Hence, it could be concluded that lactate
concentration changes in NIR spectra could only be
predicted accurately, when the pH of the sample is
also known. However, similar studies should also be
produced in complex biological fluids like serum and
whole blood in order to verify the observations. These
media might pose challenges because of the presence
of scatterers, which also absorb in the NIR spectral
region. The inclusion of more data-sets with different
pH values and media together with nonlinear models
(such as Support Vector Regression (SVR)) might
address these potential challenges.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of
this article.
Funding
The author(s) disclosed receipt of the following financial
support for the research, authorship, and/or publication
of this article: This research was supported by the
Engineering and Physical Sciences Research Council
(EPSRC) under the Healthcare Technologies theme (EP/
R003750=1).
ORCID iD
Nystha Baishya https://orcid.org/0000-0002-2231-6132
References
1. Seheult J, Fitzpatrick G and Boran G. Lactic acidosis:
an update. Clin Chem Lab Med 2017; 55: 322–333.
2. Vincent J-L, Cortes DO and Acheampong A. Current
haemodynamic management of septic shock. Presse
Med 2016; 45: e99–e103.
3. Trzeciak S, Dellinger RP, Chansky ME, et al. Serum
lactate as a predictor of mortality in patients with infec-
tion. Intensive Care Med 2007; 33: 970–977.
4. Green JP, Berger T, Garg N, et al. Serum lactate is a
better predictor of short-term mortality when stratified
by c-reactive protein in adult emergency department
patients hospitalized for a suspected infection. Ann
Emerg Med 2011; 57: 291–295.
5. del Portal DA, Shofer F, Mikkelsen ME, et al.
Emergency department lactate is associated with mor-
tality in older adults admitted with and without infec-
tions. Acad Emerg Med 2010; 17: 260–268.
6. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum
lactate is associated with mortality in severe sepsis inde-
pendent of organ failure and shock. Crit Care Med
2009; 37: 1670–1677.
7. Baysan M, Baroni GD, van Boekel AM, et al. The
added value of lactate and lactate clearance in predic-
tion of in-hospital mortality in critically ill patients with
sepsis. Crit Care Explor 2020; 2: e0087.
8. Kjelland CB and Djogovic D. The role of serum lactate
in the acute care setting. J Intensive Care Med 2010; 25:
286–300.
9. Cerovic O, Golubovic V, Spec-Marn A, et al.
Relationship between injury severity and lactate levels
in severely injured patients. Intensive Care Med 2003;
29: 1300–1305.
10. Li S, Peng K, Liu F, et al. Changes in blood lactate
levels after major elective abdominal surgery and the
association with outcomes: a prospective observational
study. J Surg Res 2013; 184: 1059–1069.
11. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lac-
tate clearance is associated with improved outcome in
severe sepsis and septic shock. Crit Care Med 2004; 32:
1637–1642.
12. Fuller BM and Dellinger RP. Lactate as a hemodynam-
ic marker in the critically ill. Curr Opin Crit Care 2012;
18: 267–272.
13. Levy MM, Evans LE and Rhodes A. The surviving
sepsis campaign bundle: 2018 update. Intensive Care
Med 2018; 44: 925–928.
14. Lee S, Hong Y, Park D, et al. Lactic acidosis not hyper-
lactatemia as a predictor of inhospital mortality in
septic emergency patients. Emerg Med J 2008; 25:
659–665.
15. Montagnani A and Nardi R. Lactic acidosis, hyperlac-
tatemia and sepsis. Ital J Med 2016; 10: 282–288.
16. Wernly B, Heramvand N, Masyuk M, et al. Acidosis
predicts mortality independently from hyperlactatemia
in patients with sepsis. Eur J Inter Med 2020; 76: 76–81.
17. Bellomo R and Ronco C. The pathogenesis of lactic
acidosis in sepsis. Curr Opin Crit Care 1999; 5: 452–457.
18. Ronco JJ, Fenwick JC, Tweeddale MG, et al.
Identification of the critical oxygen delivery for
anaerobic metabolism in critically ill septic and nonsep-
tic humans. JAMA 1993; 270: 1724–1730.
19. Rudd KE, Johnson SC, Agesa KM, et al. Global,
regional, and national sepsis incidence and mortality,
1990-2017: analysis for the global burden of disease
study. Lancet (London, England) 2020; 395: 200–211.
20. Zhou F, Yu T, Du R, et al. Clinical course and risk
factors for mortality of adult inpatients with covid-19 in
Wuhan, china: a retrospective cohort study. Lancet
2020; 395: 1054–1062.
21. Lafrance D, Lands LC, Hornby L, et al. Near-infrared
spectroscopic measurement of lactate in human plasma.
Appl Spectrosc 2000; 54: 300–304.
22. Lafrance D, Lands LC, Hornby L, et al. Lactate mea-
surement in whole blood using near infrared spectros-
copy. Can J Anal Sci Spectrosc 2000; 45: 36–40.
23. Lafrance D. Measurement of lactate in whole human
blood with near-infrared transmission spectroscopy.
Talanta 2003; 60: 635–641.
24. Soller BR, Micheels RH, Coen J, et al. Feasibility of
non-invasive measurement of tissue pH using near-
infrared reflectance spectroscopy. J Clin Monit 1996;
12: 387–395.
25. Alam K, Rohrscheib MR, Franke JE, et al.
Measurement of pH in whole blood by near-infrared
spectroscopy. Appl Spectrosc 1999; 53: 316–324.
26. Rosen NA, Charash WE and Hirsch EF. Near-infrared
spectrometric determination of blood pH. J Surg Res
2002; 106: 282–286.
27. Ferrari E, Foca G, Vignali M, et al. Adulteration of the
anthocyanin content of red wines: perspectives for
authentication by Fourier transform-near infrared and
1h NMR spectroscopies. Anal Chim Acta 2011; 701:
139–151.
28. Liu F, He Y, Wang L, et al. Detection of organic acids
and pH of fruit vinegars using near-infrared spectros-
copy and multivariate calibration. Food Bioprocess
Technol 2011; 4: 1331–1340.
29. Eldin AB. Near infra red spectroscopy, wide spectra of
quality control. London: IntechOpen, 2011.
30. Baishya N, Momouei M, Budidha K, et al. Near infrared
spectrometric investigation of lactate in a varying pH
buffer. J. Near Infrared Spectrosc 2020; 28: 328–333.
31. Baishya N, Mamouei M, Budidha K, et al.
Investigations into the effects of pH on quantitative
measurements of lactate in biological media using
ATR-FTIR spectroscopy. Molecules 2020; 25: 3695.
32. Yano T, Matsushige H, Suehara K-I, et al. Measurement
of the concentrations of glucose and lactic acid in peri-
toneal dialysis solutions using near-infrared spectrosco-
py. J Biosci Bioeng 2000; 90: 540–544.
33. Kossowski T, Kossowska K and Stasinski R. Non-
invasive measurement of chemical compounds levels
in human body. Meas Autom Monit 2017; 63: 200–202.
34. Ube T, Yoneyama Y and Ishiguro T. In situ measure-
ment of the pH-dependent transmission infrared spec-
tra of aqueous lactic acid solutions. Anal Sci 2017; 33:
1395–1400.
35. Abdi H. Partial least squares regression and projection
on latent structure regression (PLS regression). WIREs
Comp Stat 2010; 2: 97–106.
